Results 201 to 210 of about 949,142 (303)
British Journal of Clinical Pharmacology, EarlyView.Abstract Aim The aim of this systematic review was to assess all available clinical data regarding the use of a single dose of basiliximab in solid organ transplantation compared to the standard double dosage, with particular interest in efficacy, safety and cost‐savings.
Alessio Provenzani +4 more
wiley +1 more source
Harnessing co-operative immune augmentation by contact allergens to enhance the efficacy of viral vaccines. [PDF]
Contact Dermatitis, 2020 Cunningham LS +5 more
europepmc +1 more source
Health disparities in chronic liver disease
Hepatology, EarlyView., 2022 Abstract The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Health disparities occur when plausibly avoidable health differences are experienced by socially disadvantaged populations.
Ani Kardashian +3 more
wiley +1 more source
The Safety and Efficacy of Live Viral Vaccines in Patients With Cartilage-Hair Hypoplasia. [PDF]
Front Immunol, 2020 Vakkilainen S +8 more
europepmc +1 more source
Understanding protein subunit COVID-19 vaccines [PDF]
Updated July 20, 2022What You Need to Know\u2022 Protein subunit COVID-19 vaccines contain pieces (proteins) of the virus that causes COVID-19; these proteins are called the \u201cspike protein.\u201d\u2022 Protein subunit COVID-19 vaccines also contain ...
core
Efficacy, safety and cost‐effectiveness of CAR‐T therapy
British Journal of Clinical Pharmacology, EarlyView.CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher +7 more
wiley +1 more source
Identification of novel neutralizing determinants for protection against HCV
Hepatology, EarlyView., 2022 Identification of novel neutralizing determinants for protection against hepatitis C virus. Abstract Background and Aims HCV evasion of neutralizing antibodies (nAb) results in viral persistence and poses challenges to the development of an urgently needed vaccine.
Garazi P. Alzua +12 more
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aim Novel oral polio vaccine type 2 (nOPV2) was used under the WHO emergency use listing for circulating vaccine‐derived polio virus (cVDPV) outbreaks from 2021 to 2023. We assessed nOPV2 adverse events following immunization (AEFIs) and compared its safety profile to other vaccines using VigiBase.
Comfort Kunak Ogar +6 more
wiley +1 more source
The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines. [PDF]
NPJ Vaccines, 2020 Shang W, Yang Y, Rao Y, Rao X.
europepmc +1 more source